Synovian®

DRUG2 trials

Sponsors

LG Chem, DALIM TISSEN Co., Ltd.

Conditions

Cartilage Defects of the KneeDegenerative Joint Disease of KneeKnee OsteoarthritisKnee Pain ArthritisOsteoarthritisOsteoarthritis in the Knee

Unknown Phase

Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

CompletedNCT04369261

LG ChemOsteoarthritis in the Knee

Start: 2018-03-09End: 2019-08-08Updated: 2020-04-30

Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage

RecruitingNCT07267793

DALIM TISSEN Co., Ltd.Cartilage Defects of the Knee, Degenerative Joint Disease of Knee, Knee Osteoarthritis +2

Start: 2025-07-03End: 2027-06-01Target: 194Updated: 2026-09-17

Related Papers

Safety of a single intra-articular injection of LBSA0103 hyaluronic acid in patients with osteoarthritis of the knee: a multicenter, single-arm, prospective, cohort study

Current Medical Research and Opinion2021-07-016 citations